Serum Interleukin-18 Levels Are Associated With Nephropathy and Atherosclerosis in Japanese Patients With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Interleukin (IL)-18 is a proinflammatory cytokine secreted from mononuclear cells. Serum concentration of IL-18 is a strong predictor of death in patients with cardiovascular diseases. Recent studies have shown that microinflammation is involved in the pathogenesis of diabetic nephropathy as well as of cardiovascular diseases. This study aimed to test the hypothesis that the serum level of IL-18 is a common predictor of nephropathy and atherosclerosis in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS—Eighty-two Japanese patients with type 2 diabetes and 55 age- and sex-matched healthy control subjects were enrolled. Patients with renal dysfunction (creatinine clearance <1 ml/s) were excluded. We assessed clinical parameters and measured serum and urinary IL-18 levels, serum IL-6 levels, carotid intima-media thickness (IMT), and brachial-ankle pulse wave velocity (baPWV) in all patients. Further, we evaluated changes of urinary albumin excretion rate (AER) after 6 months in 76 diabetic patients. RESULTS—Serum and urinary IL-18 levels were significantly elevated in patients with type 2 diabetes as compared with control subjects (serum IL-18 179 ± 62 vs. 121 ± 55 pg/ml, P < 0.001; urinary IL-18 97 ± 159 vs. 47 ± 54 pg/ml, P = 0.035). Univariate linear regression analysis showed significant positive correlations between serum IL-18 and AER (r [correlation coefficient] = 0.525, P < 0.001), HbA1c (r = 0.242, P = 0.029), high-sensitivity C-reactive protein (hs-CRP) (r = 0.240, P = 0.031), and urinary β-2 microglobulin (r = 0.235, P = 0.036). Serum IL-18 levels also correlated positively with carotid IMT (r = 0.225, P = 0.042) and baPWV (r = 0.232, P = 0.040). We also found a significant correlation between urinary IL-18 and AER (r = 0.309, P = 0.005). Multivariate linear regression analysis showed that AER (standard correlation coefficients [B] = 0.405, P < 0.001) and hs-CRP (B = 0.207, P = 0.033) were independently associated with serum IL-18 levels. AER was also independently associated with urinary IL-18 levels (B = 0.295, P = 0.005). Moreover, serum and urinary IL-18 levels correlated positively with AER after 6 months (r = 0.489, P < 0.001 and r = 0.320, P = 0.005) and changes in AER during the follow-up period (r = 0.268, P = 0.018 and r = 0.234, P = 0.042). CONCLUSIONS—Serum levels of IL-18 might be a predictor of progression of diabetic nephropathy as well as cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cloning of a new cytokine that induces IFN-γ production by T cells
Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995) · Nature · doi:10.1038/378088a0 · Cited by 2,600 · cited 1×
“IL-18 is a potent proinflammatory cytokine that induces interferon(28), which in turn induces functional chemokine receptor expressions in human mesangial cells (29).”
BackgroundEsposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961 · cited 2×
“Activation of nuclear factor- B through oxidative stress induced by hyperglycemia increases concentrations of circulating proinflammatory cytokines (2).”
BackgroundInterleukin-18 Is a Strong Predictor of Cardiovascular Death in Stable and Unstable Angina
Blankenberg, S., Tiret, L., Bickel, C., Peetz, D., Cambien, F., Meyer, J., & Rupprecht, H. J. (2002) · Circulation · doi:10.1161/01.cir.0000020546.30940.92 · Cited by 568 · cited 1×
“High serum IL-18 concentrations have recently been identified as a strong predictor of death in patients with coronary artery disease (9) and acute ischemic stroke (10).”
BackgroundPlasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
Pickup, J. C., Chusney, G. D., Thomas, S. M., & Burt, D. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00622-6 · Cited by 566 · cited 1×
“(4,5,30) and may contribute to maintain microinflammation in renal tissues of patients with type 2 diabetes.”
BackgroundImpaired IL-18 processing protects caspase-1–deficient mice from ischemic acute renal failure
Melnikov, V. Y., Ecder, T., Fantuzzi, G., Siegmund, B., Lucia, M. S., Dinarello, C. A., Schrier, R. W., & Edelstein, C. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12089 · Cited by 476 · cited 1×
“Recently, several studies have demonstrated that proximal tubular cells are potential sources of IL-18 as well as monocytes/macrophages and T cells in ischemic acute tubular necrosis in mice (33,34).”
BackgroundFesta, A., D'agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00331.x · Cited by 369 · cited 1×
“Several reports indicate that high-sensitivity C-reactive protein (hs-CRP) (3) and proinflammatory cytokines such as interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)- , and IL-18 are elevated in patients with type 2 diabetes (4–7).”
BackgroundMelnikov, V. Y., Faubel, S. G., Siegmund, B., Lucia, M. S., Ljubanović, D. G., & Edelstein, C. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15623 · Cited by 341
Melnikov, V. Y., Faubel, S., Siegmund, B., Lucia, M. S., Ljubanovic, D., & Edelstein, C. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215623 · Cited by 316
Okada, S., Shikata, K., Matsuda, M., Ogawa, D., Usui, H., Kido, Y., Nagase, R., Wada, J., Shikata, Y., & Makino, H. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2586 · Cited by 298
Self-citationMicroalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease
Garg, J. P., & Bakris, G. L. (2002) · Vascular Medicine · doi:10.1191/1358863x02vm412ra · Cited by 278 · cited 1×
“Microalbuminuria is a predictor of cardiovascular and renal risk in diabetes (13) and nondiabetes (13,14).”
BackgroundMoriwaki, Y., Yamamoto, T., Shibutani, Y., Aoki, E., Tsutsumi, Z., Takahashi, S., Okamura, H., Koga, M., Fukuchi, M., & Hada, T. (2003) · Metabolism · doi:10.1053/meta.2003.50096 · Cited by 270 · cited 2×
“(19) reported that serum IL-18 and tumor necrosis factor (TNF)- levels were significantly elevated in diabetic patients with microalbunimuria as compared with normoalbuminuria, whereas serum IL-6 levels were not elevated in diabetic patients with microalbuminuria.”
BackgroundNavarro, J. F., Mora, C., Macıéa, M., & Garcıéa, J. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00408-6 · Cited by 238 · cited 1×
“The close correlation between serum and urinary IL-18 levels and AER strongly suggest a relationship between low-grade inflammation and albuminuria in patients with type 2 diabetes, as recently described (15,27).”
BackgroundDandona, P., Kumar, V., Aljada, A., Ghanim, H., Syed, T., Hofmayer, D., Mohanty, P., Tripathy, D., & Garg, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021836 · Cited by 207 · cited 2×
“Some studies have reported that angiotensin II blockade reduced production of inflammation molecules, including CRP (35), TNF- , and IL-18 (36).”
BackgroundSugimoto, H., Shikata, K., Hirata, K., Akiyama, K., Matsuda, M., Kushiro, M., Shikata, Y., Miyatake, N., Miyasaka, M., & Makino, H. (1997) · Diabetes · doi:10.2337/diab.46.12.2075 · Cited by 193
Self-citationIn Situ Hybridization of Interleukin 6 in Diabetic Nephropathy
Suzuki, D., Miyazaki, M., Naka, R., Koji, T., Yagame, M., Jinde, K., Endoh, M., Nomoto, Y., & Sakai, H. (1995) · Diabetes · doi:10.2337/diab.44.10.1233 · Cited by 175
Yamashita, H., Shimada, K., Seki, E., Mokuno, H., & Daida, H. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03097-7 · Cited by 130 · cited 1×
“Diabetes Care 28:2890–2895, 2005 L ow-grade inflammation (microinflammation) occurs in diabetic patients as well as those with cardiovascular diseases (1,2).”
BackgroundSerum interleukin-8 level is increased in diabetic patients
Available, N. A. N. (1999) · Diabetologia · doi:10.1007/s001250051124 · Cited by 127
Usefulness of a Highly Sensitive Urinary and Serum IL-6 Assay in Patients with Diabetic Nephropathy
Shikano, M., Sobajima, H., Yoshikawa, H., Toba, T., Kushimoto, H., Katsumata, H., Tomita, M., & Kawashima, S. (2000) · Nephron · doi:10.1159/000045634 · Cited by 121
Aso, Y., Okumura, K.-I., Takebayashi, K., Wakabayashi, S., & Inukai, T. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2622 · Cited by 118 · cited 3×
“Carotid intima-media thickness (IMT) measured by carotid ultrasound is a useful tool for assessing cardiovascular diseases in diabetes (11), and a clinical study demonstrated that carotid IMT in patients with high IL-18 shows a greater thickness than in patients with normal IL-18 (12).”
BackgroundMethod山下, 晴. (2003) · Medical Entomology and Zoology · Cited by 114
Increased expression of selectins in kidneys of patients with diabetic nephropathy
Hirata, K., Shikata, K., Matsuda, M., Akiyama, K., Sugimoto, H., Kushiro, M., & Makino, H. (1998) · Diabetologia · doi:10.1007/s001250050888 · Cited by 114
Self-citationLane, J. T. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00247.2003 · Cited by 106 · cited 1×
“Microalbuminuria is a predictor of cardiovascular and renal risk in diabetes (13) and nondiabetes (13,14).”
BackgroundCytokine Milieu Tends Toward Inflammation in Type 2 Diabetes
Esposito, K., Nappo, F., Giugliano, F., Palo, C. D., Ciotola, M., Barbieri, M., Paolisso, G., & Giugliano, D. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1647 · Cited by 104
Montero, M. T., Hernández, O., Suárez, Y., Matilla, J., Ferruelo, A. J., Martı́nez-Botas, J., Gómez-Coronado, D., & Lasunción, M. A. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00417-2 · Cited by 97
Dai, S., Matsuno, H., Nakamura, H., Nishioka, K., & Yudoh, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20064 · Cited by 89
Enhanced Acute-Phase Response and Oxidative Stress in Older Adults with Type II Diabetes
Arnalich, F., Hernanz, A., López-Maderuelo, D., Peña, J., Camacho, J., Madero, R., Vázquez, J., & Montiel, C. (2000) · Hormone and Metabolic Research · doi:10.1055/s-2007-978662 · Cited by 89
Aso, K., Miyata, M., Kubo, T., Hashiguchi, H., Fukudome, M., Fukushige, E., Koriyama, N., Nakazaki, M., Minagoe, S., & Tei, C. (2003) · Hypertension Research · doi:10.1291/hypres.26.807 · Cited by 81
Güler, S., Çakır, B., Demirbaş, B., Yönem, A., Odabaşı, E., Önde, U., Aykut, Ö., & Gürsoy, G. (2002) · Hormone Research in Paediatrics · doi:10.1159/000064664 · Cited by 77 · cited 1×
“(4,5,30) and may contribute to maintain microinflammation in renal tissues of patients with type 2 diabetes.”
BackgroundInterleukin-18 in acute ischaemic stroke patients
Zaremba, J., & Losy, J. (2003) · Neurological Sciences · doi:10.1007/s10072-003-0096-0 · Cited by 73 · cited 1×
“High serum IL-18 concentrations have recently been identified as a strong predictor of death in patients with coronary artery disease (9) and acute ischemic stroke (10).”
BackgroundActivation and suppression of renin–angiotensin system in human dendritic cells
Lapteva, N., Ide, K., Nieda, M., Ando, Y., Hatta‐Ohashi, Y., Minami, M., Dymshits, G. M., Egawa, K., Juji, T., & Tokunaga, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00855-0 · Cited by 70 · cited 2×
“ACEIs inhibit lipopolysaccharide-induced production of TNF- , IL-1 , IL-10, IL-12, and IL-18 in human monocyte-derived dendritic cells (36).”
BackgroundTaniwaki, H., Nishizawà, Y., Kawagishi, T., Ishimura, E., Emoto, M., Okamura, T., Okuno, Y., & Morii, H. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1848 · Cited by 70
Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-α and Fas (CD95)
Mariño, E., & Cardier, J. E. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00150-9 · Cited by 70
Stuyt, R. J. L., Netea, M. G., Geijtenbeek, T. B. H., Kullberg, B. J., Dinarello, C. A., & van der Meer, J. W. M. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01747.x · Cited by 64 · cited 3×
“IL-18 is known to lead to production of other proinflammatory cytokines (20), endothelial apoptosis (21), upregulation of ICAM-1 (22), and hyperhomocysteinemia (12).”
BackgroundInflammation and pathogenesis of diabetic nephropathy
Mora, C., & Navarro‐González, J. F. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.005 · Cited by 51 · cited 2×
“The close correlation between serum and urinary IL-18 levels and AER strongly suggest a relationship between low-grade inflammation and albuminuria in patients with type 2 diabetes, as recently described (15,27).”
BackgroundIFNγ induces functional chemokine receptor expression in human mesangial cells
Schwarz, M., WAHL, M., Resch, K., & Radeke, H. H. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01829.x · Cited by 40
Mesangial cell-matrix interactions. Effects on mesangial cell growth and cytokine secretion.
Ruef, C., Kashgarian, M. J., & COLEMAN, D. L. (1992) · PubMed · Cited by 35
Plasma Interleukin-18 Concentrations Are Elevated in Type 2 Diabetes
Esposito, K., Marfella, R., & Giugliano, D. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.272 · Cited by 34
Stephens, J. W., Hurel, S. J., Acharya, J., & Humphries, S. E. (2004) · Cardiovascular Diabetology · doi:10.1186/1475-2840-3-2 · Cited by 30
Parikh, A., & Daneman, D. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/152091504322783440 · Cited by 23
Peters, A. L., & Mathur, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.272-a · Cited by 22
Effect of Losartan on Plasma C-Reactive Protein in Type 2 Diabetic Patients With Microabluminuria
Tan, K. C. B., Chow, W.-S., Wong, Y., Shiu, S. W. M., & Tam, S. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1254 · Cited by 14 · cited 1×
“(37) report that ARB reduces AER in diabetic nephropathy with no significant change of hs-CRP.”
Background
Cited by
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Navarro-González, J. F., Mora-Fernández, C., de Fuentes, M. M., & García-Pérez, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.51 · Cited by 1,072
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Samsu, N. (2021) · BioMed Research International · doi:10.1155/2021/1497449 · Cited by 1,001
The Role of Inflammatory Cytokines in Diabetic Nephropathy
Navarro-González, J. F., & Mora-Fernández, C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091048 · Cited by 932
Inflammation and the pathogenesis of diabetic nephropathy
Wada, J., & Makino, H. (2013) · Clinical Science · doi:10.1042/cs20120198 · Cited by 775
Self-citationRelationship between Oxidative Stress and Inflammatory Cytokines in Diabetic Nephropathy
Elmarakby, A. A., & Sullivan, J. C. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00218.x · Cited by 641
Metadata
- Authors
- Nakamura, A., Shikata, K., Hiramatsu, M., Nakatou, T., Kitamura, T., Wada, J., Itoshima, T., & Makino, H.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2005-12-01
- Volume
- 28
- Issue
- 12
- Pages
- 2890-2895
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2057087278
- Cited by
- 218
- References
- 41
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.